ProtoKinetix is building value for investors through licensing and joint ventures with business partners, utilizing our internationally patented technology– which is comprised of a family of glycoprotein compounds – targeting biotechnology applications where existing and developing businesses have requirements that AAGPs™ – anti-aging glycopeptides – will dramatically improve. The biotechnology business is often subject to expensive and time consuming regulatory processes. Our approach is to expedite the development of our technology primarily through business relationships that provide us with leading-edge technical and marketing expertise to expedite the time lines to place products on the shelf. ProtoKinetix is not about building a business with “bricks and mortar.” We believe there are so many AAGP™ applications that can best be reached through strategic business relationships. We assess each opportunity with return on investment as the priority. Defining and measuring each agreement based upon corporate investment, time line to market, strength of the organization within a specific market segment and marketing strengths. As we build the value of AAGP™ we are also taking steps to generate revenue through sales of products in markets that do not require regulatory oversight.
(PKTX).... AAGP™ was developed by our lead scientist (Dr. Geraldine Deliencourt) who synthesized Anti-Freeze Glyco Protein found in fish, plants and reptiles who inhabit arctic climates. The AAGP™ was patented by ProtoKinetix and has evolved into a family of molecules that have proven to be very stable and non-toxic with a widely ranged application spectrum. After years of exhaustive tests and studies the following results can be summarized as follows:
i. AAGP™ increases cell function and viability ii. Tests showed an ability to repair after damage iii. This very small molecule (580-Daltons) has a unique penetration capability iv. Dramatically extends the shelf live of blood platelets and organ cells v. Very effective as an additive to DMSO in cryopreservation (-196˚C) of cells and tissues vi. Studies show strong anti-inflammatory response which could be useful in treating many diseases vii. Clearly prove an ability to enhance the yield on islet transplantation to correct diabetes (University of Alberta) viii. Protects skin cells from UV radiation and such harsh toxins as H2O2 ix. Protective effect increases significantly as an additive to Co-Enzyme Q10 x. Enhances cellular growth and function xi. Increases yield and viability in the preservation of stem cells xii. Strong protective agent in the freezing / thawing of processed umbilical cord blood